Key result
Percutaneous coronary intervention significantly improved mean left ventricular ejection fraction from 34.9% to 42.1% at 3 months in patients with multi-vessel coronary artery disease and LVEF <40%.
Why the study?
This study evaluated changes in baseline left ventricular function and clinical symptoms in patients with multi-vessel coronary artery disease after multi-vessel PCI.
Does percutaneous coronary intervention improve left ventricular ejection fraction and angina symptoms in patients with multi-vessel coronary artery disease and LVEF <40%?
Observational (n=48)
No
Does percutaneous coronary intervention improve left ventricular ejection fraction and angina symptoms in patients with multi-vessel coronary artery disease and LVEF <40%?
In patients with multi-vessel coronary artery disease and LVEF <40%, PCI is associated with significant improvements in LVEF and angina symptoms at 3 months.
Hypothesis-generating for PCI in low-LVEF multi-vessel disease; leaves open whether randomized trials would confirm benefit.
Background: The present study evaluated the changes in baseline left ventricular function and clinical symptoms in multi-vessel coronary artery disease patients after multi-vessel percutaneous coronary intervention.Methods: This was a prospective, observational study conducted at Medical Super-speciality Hospital, Kolkata, India, between August 2017 and August 2019. The study included 48 patients who were diagnosed with ≥2 coronary artery stenosis of ≥50% in native coronary arteries with left ventricular ejection fraction (LVEF) <40%. Echocardiography was performed before and after 3 months of the procedure to observe LVEF. Canadian Cardiovascular Society (CCS) score was calculated before and after 3 months after PCI.Results: Mean age of the patients was 61.89±9.96 years and 89.6% patients were male. Mean LVEF before and after angioplasty was 34.9±4.95% and 42.06±8.78%, respectively (p=0.001). CCS score before and after angioplasty was 2.89 and 1.83, respectively (p=0.001).Conclusions: The results displayed significant improvement in clinical symptoms as well as LVEF after PCI in patients with multi-vessel disease with LVEF <40%. These results will be helpful to conduct larger randomized trials with long term follow-up in order to prove the safety and effectiveness of PCI in such patients over coronary artery bypass grafting.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2020) conducted an observational in Multi-vessel coronary artery disease with left ventricular dysfunction (n=48). Percutaneous coronary intervention (PCI) vs. Baseline (pre-intervention) was evaluated on Mean left ventricular ejection fraction (LVEF) (p=0.001). Percutaneous coronary intervention significantly improved mean left ventricular ejection fraction from 34.9% to 42.1% at 3 months in patients with multi-vessel coronary artery disease and LVEF <40%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: